Study of EQ001 (Itolizumab) in Systemic Lupus Erythematosus With or Without Active Proliferative Nephritis
Clinical trial NCT04128579 · COMPLETED
Trial details
- NCT number
- NCT04128579
- Sponsor
- Biocon Limited
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-01
- Primary completion
- 2023-11-16
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.